Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
16.20
-0.44 (-2.64%)
May 28, 2026, 3:00 PM CST

Sansure Biotech Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9,30210,85813,00111,18712,74723,600
Market Cap Growth
-13.74%-16.48%16.22%-12.24%-45.99%-48.22%
Enterprise Value
6,6258,0458,9826,4087,41718,716
Last Close Price
16.2018.9122.1018.5520.0534.89
PE Ratio
61.6554.5847.1730.766.5810.52
Forward PE
37.108.198.198.198.1912.20
PS Ratio
5.806.618.9211.111.985.23
PB Ratio
1.291.511.771.511.703.70
P/TBV Ratio
1.581.871.881.621.723.73
P/FCF Ratio
----6.3715.69
P/OCF Ratio
42.9059.0247.37256.934.9812.57
EV/Sales Ratio
4.134.906.166.361.154.15
EV/EBITDA Ratio
17.0819.4233.5380.303.277.28
EV/EBIT Ratio
40.6338.2270.58-3.387.41
EV/FCF Ratio
-40.34---3.7112.44
Debt / Equity Ratio
0.160.160.060.010.000.00
Debt / EBITDA Ratio
2.992.691.530.400.010.01
Debt / FCF Ratio
----0.010.01
Net Debt / Equity Ratio
-0.38-0.42-0.59-0.64-0.75-0.73
Net Debt / EBITDA Ratio
-7.03-7.24-16.08-59.44-2.48-1.81
Net Debt / FCF Ratio
16.7016.1429.3713.64-2.82-3.10
Asset Turnover
0.170.180.170.110.790.72
Inventory Turnover
1.000.990.730.778.043.97
Quick Ratio
3.833.977.055.984.488.29
Current Ratio
4.264.377.676.474.798.99
Return on Equity (ROE)
1.57%2.12%3.06%4.66%27.88%40.31%
Return on Assets (ROA)
1.10%1.45%0.93%-0.15%16.86%25.17%
Return on Invested Capital (ROIC)
3.56%5.12%3.86%-0.78%102.20%186.47%
Return on Capital Employed (ROCE)
2.00%2.50%1.60%-0.30%28.90%39.30%
Earnings Yield
1.69%1.83%2.12%3.25%15.19%9.50%
FCF Yield
-1.77%-1.71%-1.13%-3.11%15.69%6.37%
Dividend Yield
3.23%-2.38%2.49%6.47%2.18%
Payout Ratio
213.41%167.73%97.39%110.10%33.92%19.61%
Buyback Yield / Dilution
-2.08%0.22%0.05%-0.26%0.59%-6.55%
Total Shareholder Return
1.14%0.22%2.42%2.23%7.07%-4.37%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.